Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, April 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 322 articles:
HTML format


 

Single Articles

  1. POTTER R, Tanderup K, Schmid MP, Jurgenliemk-Schulz I, et al
    MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
    Lancet Oncol. 2021;22:538-547.
    PubMed    
    Abstract available

  2. FRANCESCHI S
    Genomic characterisation of cervical cancer and human papillomavirus: new opportunities for precision medicine.
    Lancet Oncol. 2021;22:419-420.
    PubMed    


  3. CHEN H, Luo L, Fan S, Xiong Y, et al
    Zinc oxide nanoparticles synthesized from Aspergillus terreus induces oxidative stress-mediated apoptosis through modulating apoptotic proteins in human cervical cancer HeLa cells.
    J Pharm Pharmacol. 2021;73:221-232.
    PubMed    
    Abstract available

  4. GALICIA-CARMONA T, Arango-Bravo E, Serrano-Olvera JA, Flores-de La Torre C, et al
    ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer.
    Hum Vaccin Immunother. 2021 Apr 1:1-9. doi: 10.1080/21645515.2021.1893036.
    PubMed    
    Abstract available

  5. XU J, Ma X, Yang H, Zhang J, et al
    MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.
    Chem Pharm Bull (Tokyo). 2021;69:325-332.
    PubMed    
    Abstract available

  6. ALIMENA S, Pachigolla SL, Feldman S, Yang D, et al
    Race- and Age-Related Disparities in Cervical Cancer Mortality.
    J Natl Compr Canc Netw. 2021 Mar 31:1-7. doi: 10.6004/jnccn.2020.7665.
    PubMed    
    Abstract available

  7. MEYER HJ, Wienke A, Surov A
    Pre-treatment Apparent Diffusion Coefficient Does Not Predict Therapy Response to Radiochemotherapy in Cervical Cancer: A Systematic Review and Meta-analysis.
    Anticancer Res. 2021;41:1163-1170.
    PubMed    
    Abstract available

  8. TRIFANESCU OG, Gales LN, Serbanescu GL, Zgura AF, et al
    Long-term oncological outcome in patients with cervical cancer after 3 trimodality treatment (radiotherapy, platinum-based chemotherapy, and robotic surgery).
    Medicine (Baltimore). 2021;100:e25271.
    PubMed    
    Abstract available

  9. PERUCHO JAU, Wang M, Vardhanabhuti V, Tse KY, et al
    Association between IVIM parameters and treatment response in locally advanced squamous cell cervical cancer treated by chemoradiotherapy.
    Eur Radiol. 2021 Mar 30. pii: 10.1007/s00330-021-07817.
    PubMed    
    Abstract available

  10. SHENG SQ, Yu LY, Zhou XW, Pan HY, et al
    Paeonol prevents migration and invasion, and promotes apoptosis of cervical cancer cells by inhibiting 5lipoxygenase.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  11. GOCHENAUR L, Peterson S, Vasquez L, Adler D, et al
    Knowledge of Cervical Cancer Prevention Among Women in Amazonian Peru.
    Womens Health Rep (New Rochelle). 2020;1:270-278.
    PubMed    
    Abstract available

  12. QIU Q, Zhou Q, Luo A, Li X, et al
    Integrated analysis of virus and host transcriptomes in cervical cancer in Asian and Western populations.
    Genomics. 2021 Mar 27. pii: S0888-7543(21)00121.
    PubMed    
    Abstract available

  13. BIEGERT G, El Alam MB, Karpinets T, Wu X, et al
    Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align?
    J Microbiol Methods. 2021 Mar 27:106213. doi: 10.1016/j.mimet.2021.106213.
    PubMed    
    Abstract available

  14. LI L, Shi W, Zhou J
    Effect of CMNa combined with radiotherapy on the tumor immune microenvironment of mouse cervical cancer cell transplantation tumor model.
    Bioengineered. 2021;12:1066-1077.
    PubMed    
    Abstract available

  15. BIAN S, Zhao Y, Li F, Lu S, et al
    Knockdown of p62/sequestosome enhances ginsenoside Rh2-induced apoptosis in cervical cancer HeLa cells with no effect on autophagy.
    Biosci Biotechnol Biochem. 2021 Feb 5. pii: 6129351. doi: 10.1093.
    PubMed    
    Abstract available

  16. HAN H, Xu X
    MiR-205 Promotes the Viability, Migration, and Tube Formation of Cervical Cancer Cells In Vitro by Targeting GATA3.
    Cancer Biother Radiopharm. 2021 Mar 30. doi: 10.1089/cbr.2020.4184.
    PubMed    
    Abstract available

  17. OLAWAIYE AB, Baker TP, Washington MK, Mutch DG, et al
    The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer.
    CA Cancer J Clin. 2021 Mar 30. doi: 10.3322/caac.21663.
    PubMed    
    Abstract available

  18. ISSA T, Babi A, Azizan A, Alibekova R, et al
    Factors associated with cervical cancer screening behaviour of women attending gynaecological clinics in Kazakhstan: A cross-sectional study.
    Womens Health (Lond). 2021;17:17455065211004135.
    PubMed    
    Abstract available

  19. JAASKELAINEN E, Karkkainen H, Palmgren JE, Tolmunen T, et al
    MRI-guided brachytherapy for locally advanced cervical cancer: Program initiation, learning curve and dose delivery results in Kuopio University Hospital.
    Brachytherapy. 2021 Mar 26. pii: S1538-4721(21)00043.
    PubMed    
    Abstract available

  20. LI Z, Chen C, Liu P, Duan H, et al
    Comparison of oncological outcomes and major complications between laparoscopic radical hysterectomy and abdominal radical hysterectomy for stage IB1 cervical cancer with a tumour size less than 2 cm.
    Eur J Surg Oncol. 2021 Mar 22. pii: S0748-7983(21)00379.
    PubMed    
    Abstract available

  21. WONG CL, Choi KC, Chen J, Law BMH, et al
    A Community Health Worker-Led Multicomponent Program to Promote Cervical Cancer Screening in South Asian Women: A Cluster RCT.
    Am J Prev Med. 2021 Mar 26. pii: S0749-3797(21)00132.
    PubMed    
    Abstract available

  22. LIU YM, Liu H, Sun HL, Xu YY, et al
    Outcomes of icotinib combined with concurrent chemoradiotherapy in locally advanced cervical cancer.
    Neoplasma. 2021 Mar 30. pii: 201122N1264. doi: 10.4149/neo_2021_201122N1264.
    PubMed    
    Abstract available

  23. KIM N, Park W
    Adjuvant radiotherapy for cervical cancer in South Korea: a radiation oncology survey of the Korean Radiation Oncology Group (KROG 20-06).
    Jpn J Clin Oncol. 2021 Mar 29. pii: 6199106. doi: 10.1093.
    PubMed    
    Abstract available

  24. JAVADI S, Kundra V
    Multiparameter MRI and Clinical Factors for Predicting Early Response to Chemoradiotherapy in Cervical Cancer.
    Radiol Imaging Cancer. 2021;3:e209038.
    PubMed    


  25. JONES M, McNally LR
    A New Approach for Automated Image Segmentation of Organs at Risk in Cervical Cancer.
    Radiol Imaging Cancer. 2020;2:e204010.
    PubMed    


  26. ELMORE CE, Keim-Malpass J, Mitchell EM
    Health Inequity in Cervical Cancer Control Among Refugee Women in the United States by Country of Origin.
    Health Equity. 2021;5:119-123.
    PubMed    
    Abstract available

  27. CHENG T, Huang S
    Roles of Non-Coding RNAs in Cervical Cancer Metastasis.
    Front Oncol. 2021;11:646192.
    PubMed    
    Abstract available

  28. ZHANG H, Zhang R, Zhang G, Liu W, et al
    Clinical significance of miR-1298 in cervical cancer and its biological function in vitro.
    Oncol Lett. 2021;21:401.
    PubMed    
    Abstract available

  29. XU Y, Zheng Y, Duan Y, Ma L, et al
    MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
    Oncol Lett. 2021;21:392.
    PubMed    
    Abstract available

  30. YU G, Chen L, Hu Y, Yuan Z, et al
    Antitumor Effects of Baicalein and Its Mechanism via TGFbeta Pathway in Cervical Cancer HeLa Cells.
    Evid Based Complement Alternat Med. 2021;2021:5527190.
    PubMed    
    Abstract available

  31. MIHALY-VAJDA R, Boncz I, Elmer D, Csakvari T, et al
    Annual epidemiological and health insurance burden of cervical cancer in Hungary
    Orv Hetil. 2021;162.
    PubMed    
    Abstract available

  32. PHUNG HT, Truong MC, Nguyen LT, Dang ATV, et al
    Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam.
    Asian Pac J Cancer Prev. 2021;22:853-859.
    PubMed    
    Abstract available

  33. MAQBOOL T, Hadi F, Razzaq S, Naz S, et al
    Synergistic Effect of Barbadensis miller and Marsdenia Condurango Extracts Induces Apoptosis Promotes Oxidative Stress by Limiting Proliferation of Cervical Cancer and Liver Cancer Cells.
    Asian Pac J Cancer Prev. 2021;22:843-852.
    PubMed    
    Abstract available

  34. GRACE VMB, B L, Wilson DD
    The Effect of Indian Fig Fruit Extract on Human Papilloma Virus containing Cervical Cancer Cells (HeLa) by Decreasing the HPV18 L1 Gene Load.
    Asian Pac J Cancer Prev. 2021;22:785-791.
    PubMed    
    Abstract available

  35. AL YAHYAI T, Al Raisi M, Al Kindi R
    Knowledge, Attitudes, and Practices Regarding Cervical Cancer Screening among Omani Women Attending Primary Healthcare Centers in Oman: A Cross-Sectional.
    Asian Pac J Cancer Prev. 2021;22:775-783.
    PubMed    
    Abstract available

  36. ASLAN K, Haberal A, Akilli H, Meydanli MM, et al
    Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
    Arch Gynecol Obstet. 2021 Mar 27. pii: 10.1007/s00404-021-06030.
    PubMed    
    Abstract available

  37. FERREIRA M, Lovinfosse P, Hermesse J, Decuypere M, et al
    [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation.
    Eur J Nucl Med Mol Imaging. 2021 Mar 26. pii: 10.1007/s00259-021-05303.
    PubMed    
    Abstract available

  38. SHIN W, Ham TY, Park YR, Lim MC, et al
    Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
    Sci Rep. 2021;11:6988.
    PubMed    
    Abstract available

  39. CAMPOS NG, Scarinci IC, Tucker L, Peral S, et al
    Cost-effectiveness of offering cervical cancer screening with HPV self-sampling among African-American women in the Mississippi Delta.
    Cancer Epidemiol Biomarkers Prev. 2021 Mar 26. pii: 1055-9965.EPI-20-1673.
    PubMed    
    Abstract available

  40. MUSTAFA S, Pawar JS, Ghosh I
    Fucoidan induces ROS-dependent epigenetic modulation in cervical cancer HeLa cell.
    Int J Biol Macromol. 2021;181:180-192.
    PubMed    
    Abstract available

  41. SASSENOU J, Ringa V, Zins M, Ozguler A, et al
    Women with obesity in cervical cancer screening. The double penalty: Underscreening and income inequalities.
    Obes Res Clin Pract. 2021 Mar 24. pii: S1871-403X(21)00045.
    PubMed    
    Abstract available

  42. SPENCER JB
    How sparing is fertility-sparing surgery for early-stage cervical cancer?
    Fertil Steril. 2021 Mar 23. pii: S0015-0282(21)00217.
    PubMed    


  43. JANG GY, Kim YS, Lee SE, Lee JW, et al
    Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors.
    Cancer Immunol Immunother. 2021;70:1075-1088.
    PubMed    
    Abstract available

  44. PENG S, Tan M, Li YD, Cheng MA, et al
    PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model.
    Cancer Immunol Immunother. 2021;70:1049-1062.
    PubMed    
    Abstract available

  45. TIAN T, Gao X, Ju Y, Ding X, et al
    Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
    Arch Gynecol Obstet. 2021;303:793-801.
    PubMed    
    Abstract available

  46. FERNANDEZ-ESQUER ME, Nguyen FM, Atkinson JS, Le YC, et al
    Suc Khoe la Hanh Phuc (Health is Happiness): promoting mammography and pap test adherence among Vietnamese nail salon workers.
    Women Health. 2020;60:1206-1217.
    PubMed    
    Abstract available

  47. MIYOSHI A, Ueda Y, Kimura T
    Contemplating HPV vaccination in Japan during the time of COVID-19.
    Hum Vaccin Immunother. 2021;17:836-837.
    PubMed    
    Abstract available

  48. HAN HF, Chen Q, Zhao WW
    Long non-coding RNA RP11-284F21.9 functions as a ceRNA regulating PPWD1 by competitively binding to miR-769-3p in cervical carcinoma.
    Biosci Rep. 2020;40.
    PubMed    
    Abstract available

  49. LEE JC, Sim DY, Lee HJ, Im E, et al
    MicroRNA216b mediated downregulation of HSP27/STAT3/AKT signaling is critically involved in lambertianic acid induced apoptosis in human cervical cancers.
    Phytother Res. 2021;35:898-907.
    PubMed    
    Abstract available

  50. LIU J, Wu Z, Wang Y, Nie S, et al
    A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Int Immunopharmacol. 2020;88:106884.
    PubMed    
    Abstract available

  51. BAI H, Zhu S, Wu X, Liu X, et al
    Study on the ability of 3D gamma analysis and bio-mathematical model in detecting dose changes caused by dose-calculation-grid-size (DCGS).
    Radiat Oncol. 2020;15:161.
    PubMed    
    Abstract available

  52. KIM YM, Muthuramalingam K, Cho M
    Redox Regulation of NOX Isoforms on FAK((Y397))/SRC((Y416)) Phosphorylation Driven Epithelial-to-Mesenchymal Transition in Malignant Cervical Epithelial Cells.
    Cells. 2020;9.
    PubMed    
    Abstract available

  53. SHARMA P, Gautam SD, Rajendra S
    Importance of investigating high-risk human papillomavirus in lymph node metastasis of esophageal adenocarcinoma.
    World J Gastroenterol. 2020;26:2729-2739.
    PubMed    
    Abstract available

  54. GAO W, Wei S, Li Z, Li L, et al
    Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy.
    Nanotechnology. 2020;31:355104.
    PubMed    
    Abstract available

  55. NIEUWENHUYZEN-DE BOER GM, Dasgupta S, Ewing-Graham PC, Van Bockstal MR, et al
    Adenoid cystic carcinoma of the Bartholin gland is not HPV-related: A case report and review of literature.
    Pathol Res Pract. 2020;216:152968.
    PubMed    
    Abstract available

  56. BLONTZOS N, Iavazzo C, Giovannopoulou E, Galanopoulos G, et al
    Primary Peritoneal Serous Carcinoma Detected by Abnormal Cervical Smear: a Case Report.
    Folia Med (Plovdiv). 2020;62:195-199.
    PubMed    


  57. TONG W, Guo J, Yang C
    Tanshinone II A enhances pyroptosis and represses cell proliferation of HeLa cells by regulating miR-145/GSDMD signaling pathway.
    Biosci Rep. 2020;40.
    PubMed    
    Abstract available

  58. JIANG MY, Wu Z, Li T, Yu L, et al
    Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Cancer Prev Res (Phila). 2020;13:163-172.
    PubMed    
    Abstract available

  59. WANG CX, Ai SL, Wu B, Huang SW, et al
    Biotinylated and fluorophore-incorporated polymeric mixed micelles for tumor cell-specific turn-on fluorescence imaging of Al(3).
    J Mater Chem B. 2020;8:3557-3565.
    PubMed    
    Abstract available

  60. NASLAZI E, Hontelez JAC, Naber SK, van Ballegooijen M, et al
    The differential risk of cervical cancer in HPV vaccinated and unvaccinated women: a mathematical modelling study.
    Cancer Epidemiol Biomarkers Prev. 2021 Apr 9. pii: 1055-9965.EPI-20-1321.
    PubMed    
    Abstract available

  61. LI L, Peng Q, Gong M, Ling L, et al
    Using lncRNA Sequencing to Reveal a Putative lncRNA-mRNA Correlation Network and the Potential Role of PCBP1-AS1 in the Pathogenesis of Cervical Cancer.
    Front Oncol. 2021;11:634732.
    PubMed    
    Abstract available

  62. DANG Y, Liu Q, Long L, Luan H, et al
    The Effect of Neoadjuvant Chemotherapy Combined With Brachytherapy Before Radical Hysterectomy on Stage IB2 and IIA Cervical Cancer: A Retrospective Analysis.
    Front Oncol. 2021;11:618612.
    PubMed    
    Abstract available

  63. MA X, Zhang Q, Du J, Tang J, et al
    Integrated Analysis of ceRNA Regulatory Network Associated With Tumor Stage in Cervical Cancer.
    Front Genet. 2021;12:618753.
    PubMed    
    Abstract available

  64. BJORNHOLT SM, Sponholtz SE, Markauskas A, Froding LP, et al
    Sentinel lymph node mapping for endometrial and cervical cancer in Denmark.
    Dan Med J. 2021;68.
    PubMed    
    Abstract available

  65. ALAM Z, Shafiee Hanjani L, Dean J, Janda M, et al
    Cervical Cancer Screening Among Immigrant Women Residing in Australia: A Systematic Review.
    Asia Pac J Public Health. 2021 Apr 8:10105395211006600.
    PubMed    
    Abstract available

  66. GALVIN AM, Garg A, Matthes S, Thompson EL, et al
    Utilizing a Multidimensional Health Literacy Framework to Assess Cervical Cancer Screening Nonadherence.
    Health Educ Behav. 2021 Apr 8:10901981211001851. doi: 10.1177/10901981211001851.
    PubMed    
    Abstract available

  67. S D A, Pasumarthi D, Pasha A, Doneti R, et al
    Identification of Differentially Expressed Genes in Cervical Cancer Patients by Comparative Transcriptome Analysis.
    Biomed Res Int. 2021;2021:8810074.
    PubMed    
    Abstract available

  68. BASIJ M, Karpiouk A, Winer I, Emelianov S, et al
    Dual-Illumination Ultrasound/ Photoacoustic System for Cervical Cancer imaging.
    IEEE Photonics J. 2021;13.
    PubMed    
    Abstract available

  69. DAVEY DD
    American Cancer Society signals transition in cervical cancer screening from cytology to HPV tests.
    Cancer Cytopathol. 2021 Apr 7. doi: 10.1002/cncy.22429.
    PubMed    


  70. REZHAKE R, Wang Y, Chen F, Hu SY, et al
    Clinical evaluation of p16(INK4a) immunocytology in cervical cancer screening: A population-based cross-sectional study from rural China.
    Cancer Cytopathol. 2021 Apr 7. doi: 10.1002/cncy.22428.
    PubMed    
    Abstract available

  71. KIFF JM, Cotter M, Munro EG, Leonard ME, et al
    Cervical Cancer Screening in Postmenopausal Women: Is It Time to Move Toward Primary High-Risk Human Papillomavirus Screening?
    J Womens Health (Larchmt). 2021 Apr 7. doi: 10.1089/jwh.2020.8849.
    PubMed    
    Abstract available

  72. CHO HW, Hong JH, Lee JK
    Human papillomavirus testing as a primary screening tool for cervical cancer.
    J Gynecol Oncol. 2021;32:e56.
    PubMed    


  73. IKEDA M, Shida M, Shigeta S, Nagase S, et al
    The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee.
    J Gynecol Oncol. 2021;32:e44.
    PubMed    
    Abstract available

  74. KIM N, Park W
    Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06).
    J Gynecol Oncol. 2021;32:e43.
    PubMed    
    Abstract available

  75. HE M, Wang Y, Zhang G, Cao K, et al
    The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer.
    J Gynecol Oncol. 2021;32:e32.
    PubMed    
    Abstract available

  76. CHEN J, Xu Y, Hu H, Jin T, et al
    TCF7L1 Genetic Variants Are Associated with the Susceptibility to Cervical Cancer in a Chinese Population.
    Biomed Res Int. 2021;2021:6670456.
    PubMed    
    Abstract available

  77. ZHANG G, He F, Miao L, Wu H, et al
    Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity.
    Jpn J Clin Oncol. 2021 Apr 5. pii: 6209417. doi: 10.1093.
    PubMed    
    Abstract available


  78. Expression of Concern: Hotair contributes to cell proliferation and metastasis of cervical cancer via targeting miR-23b/MAPK1 axis.
    Biosci Rep. 2021;41.
    PubMed    


  79. LIU Y, Qiu S, Zheng X, Qiu Y, et al
    LINC00662 modulates cervical cancer cell proliferation, invasion, and apoptosis via sponging miR-103a-3p and upregulating PDK4.
    Mol Carcinog. 2021 Apr 5. doi: 10.1002/mc.23294.
    PubMed    
    Abstract available

  80. ZHOU B, Li T, Xie R, Zhou J, et al
    CircFAT1 facilitates cervical cancer malignant progression by regulating ERK1/2 and p38 MAPK pathway through miR-409-3p/CDK8 axis.
    Drug Dev Res. 2021 Apr 5. doi: 10.1002/ddr.21816.
    PubMed    
    Abstract available

  81. ZAYED S, Nguyen TK, Lin C, Boldt G, et al
    Red Blood Cell Transfusion Practices for Patients With Cervical Cancer Undergoing Radiotherapy.
    JAMA Netw Open. 2021;4:e213531.
    PubMed    
    Abstract available

  82. JANG TK, Chung H, Kwon SH, Shin SJ, et al
    Robotic Single-Site Versus Multiport Radical Hysterectomy in Early Stage Cervical Cancer: An Analysis of 62 Cases from a Single Institution.
    Int J Med Robot. 2021 Apr 4. doi: 10.1002/rcs.2255.
    PubMed    
    Abstract available

  83. QI M, Xie L, Duan G
    Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer.
    Open Life Sci. 2021;16:53-60.
    PubMed    
    Abstract available

  84. LIU W, Yao D, Huang B
    LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression.
    Open Life Sci. 2021;16:1-13.
    PubMed    
    Abstract available

  85. BHATT AR, Ganatra A, Kotecha K
    Cervical cancer detection in pap smear whole slide images using convNet with transfer learning and progressive resizing.
    PeerJ Comput Sci. 2021;7:e348.
    PubMed    
    Abstract available

  86. LIU J, Dong P, Zhou L, Wang S, et al
    The Association between Five Genetic Variants in MicroRNAs (rs2910164, rs11614913, rs3746444, rs11134527, and rs531564) and Cervical Cancer Risk: A Meta-Analysis.
    Biomed Res Int. 2021;2021:9180874.
    PubMed    
    Abstract available

  87. WANG H, Luo Q, Kang J, Wei Q, et al
    YTHDF1 Aggravates the Progression of Cervical Cancer Through m(6)A-Mediated Up-Regulation of RANBP2.
    Front Oncol. 2021;11:650383.
    PubMed    
    Abstract available

  88. LIU J, Liu S, Yang X
    Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis.
    Front Oncol. 2021;11:542063.
    PubMed    
    Abstract available

  89. PASHA A, Kumbhakar DV, Doneti R, Kumar K, et al
    Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and In Vitro Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical Cancer.
    Oxid Med Cell Longev. 2021;2021:6692628.
    PubMed    
    Abstract available

  90. GOTHWAL M, Nalwa A, Singh P, Yadav G, et al
    Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.
    J Obstet Gynaecol India. 2021;71:72-77.
    PubMed    
    Abstract available

  91. PKHAKADZE G, Bokhua Z, Asatiani T, Muzashvili T, et al
    LOSS OF CAS3 AND INCREASE OF BAX EXPRESSION ASSOCIATED WITH PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA.
    Georgian Med News. 2021;:147-151.
    PubMed    
    Abstract available

  92. CROMWELL I, Smith LW, van der Hoek K, Hedden L, et al
    Cost-effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial.
    Cancer Med. 2021 Apr 2. doi: 10.1002/cam4.3864.
    PubMed    
    Abstract available

  93. STANCA M, Capilna ME
    Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in Eastern Europe.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  94. DEL MISTRO A, Battagello J, Weis L, Bressan V, et al
    A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  95. TANIGUCHI M, Ueda Y, Yagi A, Miyoshi A, et al
    Disparity of Cervical Cancer Risk in Young Japanese Women: Bipolarized Status of HPV Vaccination and Cancer Screening.
    Vaccines (Basel). 2021;9.
    PubMed    
    Abstract available

  96. PELULLO CP, Cantore F, Lisciotto A, Di Giuseppe G, et al
    Organized Breast and Cervical Cancer Screening: Attendance and Determinants in Southern Italy.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  97. GUI B, Autorino R, Micco M, Nardangeli A, et al
    Pretreatment MRI Radiomics Based Response Prediction Model in Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  98. LASCHE M, Urban H, Gallwas J, Grundker C, et al
    HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review.
    Cells. 2021;10.
    PubMed    
    Abstract available

  99. ROSA MN, E Silva LRV, Longato GB, Evangelista AF, et al
    Bioprospecting of Natural Compounds from Brazilian Cerrado Biome Plants in Human Cervical Cancer Cell Lines.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  100. BICH-LOAN NT, Kien KT, Thanh NL, Kim-Thanh NT, et al
    Toxicity and Anti-Proliferative Properties of Anisomeles indica Ethanol Extract on Cervical Cancer HeLa Cells and Zebrafish Embryos.
    Life (Basel). 2021;11.
    PubMed    
    Abstract available

  101. HSIN MC, Hsieh YH, Hsiao YH, Chen PN, et al
    Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  102. MASADAH R, Rauf S, Pratama MY, Tiribelli C, et al
    The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  103. CAUSIN RL, Freitas AJA, Trovo Hidalgo Filho CM, Reis RD, et al
    A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression.
    Cells. 2021;10.
    PubMed    
    Abstract available

  104. LEE SA, Ho C, Troxler M, Lin CY, et al
    Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  105. QIN X, Zhou M, Lv H, Mao X, et al
    Corrigendum to "Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3" [Canc. Lett. 498 (2021) 130-141].
    Cancer Lett. 2021;508:73-75.
    PubMed    


  106. LEI G, Xin X, Hu X
    Clinical significance of kinesin family member 2A as a facilitating biomarker of disease surveillance and prognostication in cervical cancer patients.
    Ir J Med Sci. 2021 Apr 2. pii: 10.1007/s11845-021-02510.
    PubMed    
    Abstract available

  107. KIM MJ, Lee HJ, Choi MY, Kang SS, et al
    UHRF1 Induces Methylation of the TXNIP Promoter and Down-Regulates Gene Expression in Cervical Cancer.
    Mol Cells. 2021;44:146-159.
    PubMed    
    Abstract available

  108. ANIKWE CC, Ifemelumma CC, Ekwedigwe KC, Ikeoha CC, et al
    Correlates of patients' satisfaction with antenatal care services in a tertiary hospital in Abakaliki, Ebonyi State, Nigeria.
    Pan Afr Med J. 2020;37:342.
    PubMed    
    Abstract available

  109. GOSPODINOVA A, Nankov V, Tomov S, Redzheb M, et al
    Extrusion bioprinting of hydroxyethylcellulose-based bioink for cervical tumor model.
    Carbohydr Polym. 2021;260:117793.
    PubMed    
    Abstract available

  110. MERCIER AE, Prudent R, Pepper MS, De Koning L, et al
    Characterization of Signalling Pathways That Link Apoptosis and Autophagy to Cell Death Induced by Estrone Analogues Which Reversibly Depolymerize Microtubules.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  111. OLAZARAN-SANTIBANEZ F, Rivera G, Vanoye-Eligio V, Mora-Olivo A, et al
    Antioxidant and Antiproliferative Activity of The Ethanolic Extract of Equisetum Myriochaetum and Molecular Docking of Its Main Metabolites (Apigenin, Kaempferol, and Quercetin) on beta-Tubulin.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  112. CHUMDURI C, Gurumurthy RK, Berger H, Dietrich O, et al
    Opposing Wnt signals regulate cervical squamocolumnar homeostasis and emergence of metaplasia.
    Nat Cell Biol. 2021;23:184-197.
    PubMed    
    Abstract available

  113. MOYO F, Mazanderani AH, Murray T, Sherman GG, et al
    Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa.
    AIDS. 2021;35:307-316.
    PubMed    
    Abstract available

  114. HUANG P, Tan X, Chen C, Lv X, et al
    AF-SENet: Classification of Cancer in Cervical Tissue Pathological Images Based on Fusing Deep Convolution Features.
    Sensors (Basel). 2020;21.
    PubMed    
    Abstract available

  115. LI W, Wang D, Ge Y, Zhang L, et al
    Discovery and Biological Evaluation of CD147 N-Glycan Inhibitors: A New Direction in the Treatment of Tumor Metastasis.
    Molecules. 2020;26.
    PubMed    
    Abstract available

  116. WANG M, Qiao X, Cooper T, Pan W, et al
    HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
    Cell Death Dis. 2020;11:1049.
    PubMed    
    Abstract available

  117. JAKOVAC H, Stasic N, Krasevic M, Jonjic N, et al
    Expression profiles of metallothionein-I/II and megalin/LRP-2 in uterine cervical squamous lesions.
    Virchows Arch. 2021;478:735-746.
    PubMed    
    Abstract available

  118. SARAIYA M, Cheung LC, Soman A, Mix J, et al
    Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017.
    Am J Obstet Gynecol. 2021;224:366.
    PubMed    
    Abstract available

  119. PATARAPADUNGKIT N, Khonhan P, Pisuttimarn P, Pientong C, et al
    Human Papillomavirus Detection and Abnormal Anal Cytology in HIV-infected Patients Using p16/Ki-67 Dual-Staining.
    Asian Pac J Cancer Prev. 2020;21:2013-2019.
    PubMed    
    Abstract available

  120. NESSA A, Ara R, Fatema P, Nasrin B, et al
    Influence of Demographic and Reproductive Factors on Cervical Pre-Cancer and Cancer in Bangladesh.
    Asian Pac J Cancer Prev. 2020;21:1883-1889.
    PubMed    
    Abstract available

  121. XU HH, Yan WH, Lin A
    The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis.
    Front Immunol. 2020;11:1349.
    PubMed    
    Abstract available

  122. LIU Y, Ang Q, Wu H, Xu J, et al
    Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Virol J. 2020;17:104.
    PubMed    
    Abstract available

  123. LUO Q, Jiang N, Wu Q, Wang J, et al
    Prevalence and genotype distribution of HPV and cervical pathological results in Sichuan Province, China: a three years surveys prior to mass HPV vaccination.
    Virol J. 2020;17:100.
    PubMed    
    Abstract available

  124. TUOMINEN H, Al-Samadi A, Salo T, Rautava J, et al
    Human myoma tissue-based extracellular matrix models for testing the effects of irradiation on the HPV positive cells.
    Virol J. 2020;17:87.
    PubMed    
    Abstract available

  125. LI H, Li P, Huang L, Sun L, et al
    Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China.
    Virol J. 2020;17:84.
    PubMed    
    Abstract available

  126. ZHANG Y, Wang N, Ding M, Yang Y, et al
    CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8(+) T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication.
    Front Immunol. 2020;11:1012.
    PubMed    
    Abstract available

  127. KRUSE MH, Bednarczyk RA, Evans DP
    A human rights approach to understanding provider knowledge and attitudes toward the human papillomavirus vaccine in Sao Paulo, Brazil.
    Papillomavirus Res. 2020;9:100197.
    PubMed    
    Abstract available

  128. GARLAND SM, Stanley MA, Giuliano AR, Moscicki AB, et al
    IPVS statement on "Temporary HPV vaccine shortage: Implications globally to achieve equity".
    Papillomavirus Res. 2020;9:100195.
    PubMed    


  129. LIN Y, Lin Z, He F, Chen H, et al
    HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China.
    Vaccine. 2020 Feb 29. pii: S0264-410X(20)30254.
    PubMed    
    Abstract available

  130. THOMPSON EL, Wheldon CW, Rosen BL, Maness SB, et al
    Awareness and knowledge of HPV and HPV vaccination among adults ages 27-45 years.
    Vaccine. 2020 Feb 3. pii: S0264-410X(20)30079.
    PubMed    
    Abstract available

  131. RABBAN JT, Devine WP, Sangoi AR, Poder L, et al
    NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
    Histopathology. 2020;77:100-111.
    PubMed    
    Abstract available

  132. LAWTON B, Heffernan M, Wurtak G, Steben M, et al
    IPVS Policy Statement addressing the burden of HPV disease for Indigenous peoples.
    Papillomavirus Res. 2020;9:100191.
    PubMed    


  133. BONDE JH, Pedersen H, Quint W, Xu L, et al
    Clinical and analytical performance of the BD Onclarity HPV Assay with SurePath screening samples from the Danish cervical screening program using the VALGENT framework.
    J Clin Microbiol. 2019 Nov 13. pii: JCM.01518-19. doi: 10.1128/JCM.01518.
    PubMed    
    Abstract available

  134. KULKARNI A, Policarpio M, Strub S, Jembere N, et al
    Performance Indicators for Colposcopy in Ontario.
    J Obstet Gynaecol Can. 2020;42:144-149.
    PubMed    
    Abstract available

  135. DAI Z
    What Have We Missed?: The Knowledge of and Access to the HPV Vaccine and Sex Education in China.
    Health Commun. 2020;35:96-98.
    PubMed    
    Abstract available

  136. BORRERO R, Veloza MJ, Bedoya N
    Is it enough only a single T2-weighted image in sagittal plane for diagnosis and staging uterine cervical cancer?
    Eur J Radiol. 2021;139:109689.
    PubMed    


  137. SINGH G, Tyagi A, Thaper D, Kamal R, et al
    Dosimetric analysis of cervical cancer stage IIB patients treated with volumetric modulated arc therapy using plan uncertainty parameters module of Varian Eclipse treatment planning system.
    Biomed Phys Eng Express. 2021 Apr 16. doi: 10.1088/2057-1976.
    PubMed    
    Abstract available

  138. YUCEL POLAT A, Ayva ES, Gurdal H, Ozdemir BH, et al
    MiR-25 and KLF4 relationship has early prognostic significance in the development of cervical cancer.
    Pathol Res Pract. 2021;222:153435.
    PubMed    
    Abstract available

  139. BEILNER D, Kuhn C, Kost BP, Vilsmaier T, et al
    Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.
    Arch Gynecol Obstet. 2021 Apr 16. pii: 10.1007/s00404-021-06053.
    PubMed    
    Abstract available

  140. KOVALENKO LP, Korzhova KV, Zainullina LF, Nikitin SV, et al
    [Effect of 5-hydroxypyrimidine derivatives on tumor growth and cytokine concentration in blood serum of female CBA mice with cervical cancer (RSHM-5)].
    Biomed Khim. 2021;67:158-161.
    PubMed    
    Abstract available

  141. PAULINO E, Melo AC
    Advanced Cervical Cancer: Leveraging the Historical Threshold of Overall Survival.
    Rev Bras Ginecol Obstet. 2021;43:235-237.
    PubMed    


  142. NGCOBO N, Jaca A, Iwu-Jaja CJ, Mavundza E, et al
    Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination.
    Curr Opin Immunol. 2021;71:21-26.
    PubMed    
    Abstract available

  143. REZQALLA J, Alshatti M, Ibraheem A, Omar D, et al
    Human Papillomavirus (HPV): unawareness of causal role HPV infection in cervical cancer, HPV vaccine availability and HPV vaccine uptake among female schoolteachers in a Middle Eastern country.
    J Infect Public Health. 2021;14:661-667.
    PubMed    
    Abstract available

  144. WANG X, Liu S, Guan Y, Ding J, et al
    fvVaginal drug delivery approaches for localized management of cervical cancer.
    Adv Drug Deliv Rev. 2021 Apr 12. pii: S0169-409X(21)00109.
    PubMed    
    Abstract available

  145. NOH KW, Kim B, Choi CH, Kim TJ, et al
    Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation (CCRT) for Cervical Cancer on Overall Survival.
    Cancer Res Treat. 2021 Apr 15. pii: crt.2021.023. doi: 10.4143/crt.2021.
    PubMed    
    Abstract available

  146. WENTZENSEN N, Clarke MA
    Cervical Cancer Screening-Past, Present, and Future.
    Cancer Epidemiol Biomarkers Prev. 2021;30:432-434.
    PubMed    
    Abstract available

  147. BLACKBURN L, Hill C, Lindsey AL, Sinnott LT, et al
    Effect of Foot Reflexology and Aromatherapy on Anxiety and Pain During Brachytherapy for Cervical Cancer.
    Oncol Nurs Forum. 2021;48:265-276.
    PubMed    
    Abstract available

  148. ZHAO J, Cai J, Wang H, Dong W, et al
    Region-specific Risk Factors for Pelvic Lymph Node Metastasis in Patients with Stage IB1 Cervical Cancer.
    J Cancer. 2021;12:2624-2632.
    PubMed    
    Abstract available

  149. LOHMUSSAAR K, Oka R, Espejo Valle-Inclan J, Smits MHH, et al
    Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer.
    Cell Stem Cell. 2021 Apr 8. pii: S1934-5909(21)00118.
    PubMed    
    Abstract available

  150. MAURICIO D, Zeybek B, Tymon-Rosario J, Harold J, et al
    Immunotherapy in Cervical Cancer.
    Curr Oncol Rep. 2021;23:61.
    PubMed    
    Abstract available

  151. MANGANARO L, Lakhman Y, Bharwani N, Gui B, et al
    Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.
    Eur Radiol. 2021 Apr 14. pii: 10.1007/s00330-020-07632.
    PubMed    
    Abstract available

  152. BIDDELL CB, Spees LP, Smith JS, Brewer NT, et al
    Perceived Financial Barriers to Cervical Cancer Screening and Associated Cost Burden Among Low-Income, Under-Screened Women.
    J Womens Health (Larchmt). 2021 Apr 13. doi: 10.1089/jwh.2020.8807.
    PubMed    
    Abstract available


  153. Retraction: MicroRNA-505-5p functions as a tumor suppressor by targeting Cyclin-Dependent Kinase 5 in cervical cancer.
    Biosci Rep. 2021;41.
    PubMed    


  154. KELLY L, Justine S, Brandon G, Sandra H, et al
    Sweet syndrome with bitter outcomes in cervical cancer: A case report.
    Gynecol Oncol Rep. 2021;36:100749.
    PubMed    
    Abstract available

  155. HAN X, Liu S, Hosseinifard H, Imani S, et al
    Descriptive statistics of dataset from the meta-analysis and meta-regression analysis on prognostic significance of pre-treatment systemic hemato-immunological indices of cervical cancer patients.
    Data Brief. 2021;35:106925.
    PubMed    
    Abstract available

  156. NANTAJIT D, Chailapakul P, Bawornpatarapakorn S, Chamchod S, et al
    Prognostic significance of uPA and uPAR expression in patients with cervical cancer undergoing radiotherapy.
    Oncol Lett. 2021;21:423.
    PubMed    
    Abstract available

  157. YUK JS, Lee B, Kim MH, Kim K, et al
    Incidence and risk factors of VTE in patients with cervical cancer using the Korean national health insurance data.
    Sci Rep. 2021;11:8031.
    PubMed    
    Abstract available

  158. LI C, Yang S, Ma H, Ruan M, et al
    Influence of icariin on inflammation, apoptosis, invasion, and tumor immunity in cervical cancer by reducing the TLR4/MyD88/NF-kappaB and Wnt/beta-catenin pathways.
    Cancer Cell Int. 2021;21:206.
    PubMed    
    Abstract available

  159. AZLINA FA, Setyowati S, Budiati T
    Female health education package enhances knowledge, attitudes, and self-efficacy of housewives in cervical cancer screening.
    Enferm Clin. 2021;31 Suppl 2:S215-S219.
    PubMed    
    Abstract available

  160. YANG Q, Zhou Q, He X, Cai J, et al
    Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer.
    J Gynecol Obstet Hum Reprod. 2021 Apr 10:102145.
    PubMed    
    Abstract available

  161. DONG M, Gu X, Ma T, Mi Y, et al
    The role of radiotherapy in neuroendocrine cervical cancer: SEER-based study.
    Sci Prog. 2021;104:368504211009336.
    PubMed    
    Abstract available

  162. XU L, Li C, Hua F, Liu X, et al
    The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer.
    Med Oncol. 2021;38:58.
    PubMed    
    Abstract available

  163. OGDEN SN, Leskinen EA, Sarma EA, Wainwright JV, et al
    Effects of message framing on cervical cancer screening knowledge and intentions related to primary HPV testing.
    Cancer Prev Res (Phila). 2021 Apr 12. pii: 1940-6207.CAPR-20-0622.
    PubMed    
    Abstract available

  164. COTTRELL CM, Ohaegbulam GC, Smith JR, Del Priore G, et al
    Fertility-sparing treatment in cervical cancer: Abdominal trachelectomy.
    Best Pract Res Clin Obstet Gynaecol. 2021 Feb 22. pii: S1521-6934(21)00020.
    PubMed    
    Abstract available

  165. OSEI EA, Appiah S, Gaogli JE, Oti-Boadi E, et al
    Knowledge on cervical cancer screening and vaccination among females at Oyibi Community.
    BMC Womens Health. 2021;21:148.
    PubMed    
    Abstract available

  166. COLEMAN RL, Lorusso D, Gennigens C, Gonzalez-Martin A, et al
    Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
    Lancet Oncol. 2021 Apr 9. pii: S1470-2045(21)00056.
    PubMed    
    Abstract available

  167. SNIADECKI M, Minarji G, Wojtylak S, Wycinka E, et al
    Factors limiting the detection of sentinel lymph nodes in early-stage cervical cancer.
    Ginekol Pol. 2021 Apr 15. pii: VM/OJS/J/69260. doi: 10.5603/GP.a2021.0031.
    PubMed    
    Abstract available

  168. YANG Z, Francisco J, Reese AS, Spriggs DR, et al
    Addressing cervical cancer screening disparities through advances in artificial intelligence and nanotechnologies for cellular profiling.
    Biophys Rev. 2021;2:011303.
    PubMed    
    Abstract available

  169. CHEN Y, Lin H, Pi YN, Chen XX, et al
    Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.
    Front Oncol. 2021;11:616530.
    PubMed    
    Abstract available

  170. YU F, Liu J, Dong W, Xie J, et al
    The diagnostic value of miR-145 and miR-205 in patients with cervical cancer.
    Am J Transl Res. 2021;13:1825-1832.
    PubMed    
    Abstract available

  171. LIU J, Zhu H, Fu L, Xu T, et al
    Investigating the Underlying Mechanisms of Circular RNAs and Their Application in Clinical Research of Cervical Cancer.
    Front Genet. 2021;12:653051.
    PubMed    
    Abstract available

  172. LIU Y, Guo QF, Chen JL, Li XR, et al
    Correlations between alterations of T-helper 17 cells and treatment efficacy after concurrent radiochemotherapy in locally advanced cervical cancer (stage IIB-IIIB): a 3-year prospective study.
    Chin Med J (Engl). 2021 Apr 8. pii: 00029330-900000000-98661.
    PubMed    
    Abstract available

  173. ISHIGURO T, Nishikawa N, Ishii S, Yoshihara K, et al
    PET/MR imaging for the evaluation of cervical cancer during pregnancy.
    BMC Pregnancy Childbirth. 2021;21:288.
    PubMed    
    Abstract available

  174. WANG AC, Wang LQ, Li J, Li MX, et al
    [Artificial intelligence aided measurement of cervical squamous epithelial thickness and its correlation with cervical precancerous lesions].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:339-343.
    PubMed    
    Abstract available

  175. ZHU XH, Li XM, Zhang WL, Liao MM, et al
    [Application of artificial intelligence-assisted diagnosis for cervical liquid-based thin-layer cytology].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:333-338.
    PubMed    
    Abstract available


  176. [Chinese experts' consensus on digital pathological image acquisition and quality control of cervical liquid based cytology].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:319-322.
    PubMed    


  177. PANAGOPOULOS I, Andersen K, Ramslien LF, Ikonomou IM, et al
    Therapy-related Myeloid Leukemia With the Translocation t(8;19)(p11;q13) Leading to a KAT6A-LEUTX Fusion Gene.
    Anticancer Res. 2021;41:1753-1760.
    PubMed    
    Abstract available

  178. BOWDEN SJ, Bodinier B, Kalliala I, Zuber V, et al
    Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
    Lancet Oncol. 2021;22:548-557.
    PubMed    
    Abstract available

  179. KAYACAN S, Yilancioglu K, Akdemir AS, Kaya-Dagistanli F, et al
    Synergistic Effect of Apigenin and Curcumin on Apoptosis, Paraptosis and Autophagy-related Cell Death in HeLa Cells.
    Anticancer Res. 2021;41:1271-1282.
    PubMed    
    Abstract available

  180. GOLDSCHMIDT R, Chu C
    HIV Infection in Adults: Initial Management.
    Am Fam Physician. 2021;103:407-416.
    PubMed    
    Abstract available

  181. CHEN R, Qin P, Luo Q, Yang W, et al
    ER-positive endocervical adenocarcinoma mimicking endometrioid adenocarcinoma in morphology and immunohistochemical profile: A case report of application of HPV RNAscope detection.
    Medicine (Baltimore). 2021;100:e24927.
    PubMed    
    Abstract available

  182. BASU P, Alhomoud S, Taghavi K, Carvalho AL, et al
    Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation.
    JCO Glob Oncol. 2021;7:416-424.
    PubMed    
    Abstract available

  183. VERHOEVEN Y, Quatannens D, Trinh XB, Wouters A, et al
    Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  184. CORTES-GUTIERREZ EI, Davila-Rodriguez MI, Sanchez-Davila H, Fernandez JL, et al
    Quick assessment of DNA damage in cervical epithelial cells using a chromatin dispersion test.
    Arch Gynecol Obstet. 2021;303:1049-1056.
    PubMed    
    Abstract available

  185. CHEN M, Feng C, Wang Q, Li J, et al
    Comparison of reduced field-of-view diffusion-weighted imaging (DWI) and conventional DWI techniques in the assessment of Cervical carcinoma at 3.0T: Image quality and FIGO staging.
    Eur J Radiol. 2021;137:109557.
    PubMed    
    Abstract available

  186. THOBIAS AR, Patel KA, Bhatt SD, Mehta KA, et al
    Human papillomavirus: footprints in the population of western India.
    Epidemiol Health. 2021;43:e2021013.
    PubMed    
    Abstract available

  187. AMBRA R, Manca S, Leoni G, Guantario B, et al
    Involvement of miR-190b in Xbp1 mRNA Splicing upon Tocotrienol Treatment.
    Molecules. 2020;26.
    PubMed    
    Abstract available

  188. KUROSU H, Todo Y, Yamada R, Minowa K, et al
    Clinical implication of psoas muscle mass measurement for predicting death within 3 months in patients with incurable uterine cervical or corpus malignancy.
    Jpn J Clin Oncol. 2021;51:577-583.
    PubMed    
    Abstract available

  189. CRISCUOLO AA, Sesti F, Piccione E, Mancino P, et al
    Therapeutic Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women with Cervical Uterine High-Risk HPV Infection: A Retrospective Observational Study.
    Adv Ther. 2021;38:1202-1211.
    PubMed    
    Abstract available

  190. WAKULA M, Balcerak A, Rubel T, Chmielarczyk M, et al
    The interactome of multifunctional HAX1 protein suggests its role in the regulation of energy metabolism, de-aggregation, cytoskeleton organization and RNA-processing.
    Biosci Rep. 2020;40.
    PubMed    
    Abstract available

  191. YAMASHITA H, Takahashi Y, Ishizaki T, Imura H, et al
    Associations of multimorbidity with breast, cervical, and colorectal cancer screening delivery: a cross-sectional study of a nationally representative Japanese sample.
    Cancer Epidemiol. 2020;69:101798.
    PubMed    
    Abstract available

  192. OMIRE A, Budambula NLM, Kirumbi L, Langat H, et al
    Cervical Dysplasia, Infection, and Phylogeny of Human Papillomavirus in HIV-Infected and HIV-Uninfected Women at a Reproductive Health Clinic in Nairobi, Kenya.
    Biomed Res Int. 2020;2020:4945608.
    PubMed    
    Abstract available

  193. WEN X, Liu S, Cui M
    Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
    Biomed Res Int. 2020;2020:3598417.
    PubMed    
    Abstract available

  194. FANG L, Lin X, Yang Y, Song Z, et al
    Genetic variability, phylogeny and functional implication of the long control region in human papillomavirus type 16, 18 and 58 in Chengdu, China.
    Virol J. 2020;17:106.
    PubMed    
    Abstract available

  195. LORENTE S, Fernandes NCCA, Etlinger-Colonelli D, Ressio RA, et al
    High-risk Human Papillomavirus Testing for Triage of Women with Previous Cytological Abnormalities from the Vale do Ribeira Region.
    Rev Bras Ginecol Obstet. 2020;42:340-348.
    PubMed    
    Abstract available

  196. WANG J, Wang Y, Xu X, Peng S, et al
    Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy.
    Med Sci Monit. 2020;26:e922028.
    PubMed    
    Abstract available

  197. MAO Y, Zhang L, Li Y
    Application of CircEIF4G2 in Screening of Cervical Lesions.
    Clin Lab. 2020;66.
    PubMed    
    Abstract available

  198. DEUFEL CL, Epelman MA, Pasupathy KS, Sir MY, et al
    PNaV: A tool for generating a high-dose-rate brachytherapy treatment plan by navigating the Pareto surface guided by the visualization of multidimensional trade-offs.
    Brachytherapy. 2020;19:518-531.
    PubMed    
    Abstract available

  199. KISSEL M, Andraud M, Duhamel AS, Boulle G, et al
    Hypnosedation for endocavitary uterovaginal applications: A pilot study.
    Brachytherapy. 2020;19:462-469.
    PubMed    
    Abstract available

  200. DYER BA, Yuan Z, Qiu J, Shi L, et al
    Clinical feasibility of MR-assisted CT-based cervical brachytherapy using MR-to-CT deformable image registration.
    Brachytherapy. 2020;19:447-456.
    PubMed    
    Abstract available

  201. WESTON G, Dombrowski C, Harvey MJ, Iftner T, et al
    Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation.
    BMJ Open. 2020;10:e031303.
    PubMed    
    Abstract available

  202. CHENG S, Ma M, Zhang L, Liu L, et al
    CGSEA: A Flexible Tool for Evaluating the Associations of Chemicals with Complex Diseases.
    G3 (Bethesda). 2020;10:945-949.
    PubMed    
    Abstract available

  203. HUANG X, Wang B, Chen R, Zhong S, et al
    The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation.
    Front Cell Dev Biol. 2021;9:583146.
    PubMed    
    Abstract available

  204. PATRONO MG, Calvo MF, Franco JVA, Garrote V, et al
    A systematic review and meta-analysis of the prevalence of therapeutic targets in cervical cancer.
    Ecancermedicalscience. 2021;15:1200.
    PubMed    
    Abstract available

  205. ARROSSI S, Paolino M, Laudi R, Thouyaret L, et al
    Changing the paradigm of cervical cancer prevention through introduction of HPV-testing: evaluation of the implementation process of the Jujuy Demonstration Project in Argentina.
    Ecancermedicalscience. 2021;15:1199.
    PubMed    
    Abstract available

  206. FERNANDES ATG, Carvalho MOO, Avvad-Portari E, Rocha NP, et al
    A prognostic value of CD45RA(+), CD45RO(+), CCL20(+) and CCR6(+) expressing cells as 'immunoscore' to predict cervical cancer induced by HPV.
    Sci Rep. 2021;11:8782.
    PubMed    
    Abstract available

  207. SIMKIN J, Smith L, van Niekerk D, Caird H, et al
    Sociodemographic characteristics of women with invasive cervical cancer in British Columbia, 2004-2013: a descriptive study.
    CMAJ Open. 2021;9:E424-E432.
    PubMed    
    Abstract available

  208. MONTERO-MACIAS R, Koual M, Crespel C, Le Frere-Belda MA, et al
    Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report.
    J Med Case Rep. 2021;15:210.
    PubMed    
    Abstract available

  209. GETANEH A, Tegene B, Belachew T
    Knowledge, attitude and practices on cervical cancer screening among undergraduate female students in University of Gondar, Northwest Ethiopia: an institution based cross sectional study.
    BMC Public Health. 2021;21:775.
    PubMed    
    Abstract available

  210. ABEBE M, Eshetie S, Tessema B
    Prevalence of sexually transmitted infections among cervical cancer suspected women at University of Gondar Comprehensive Specialized Hospital, North-west Ethiopia.
    BMC Infect Dis. 2021;21:378.
    PubMed    
    Abstract available

  211. ANIKWE CC, Osuagwu PC, Ikeoha CC, Ikechukwu Dimejesi OB, et al
    Cervical Cancer: Assessment of Its Knowledge, Utilization of Services and Its Determinant Among Female Undergraduate Students in a Low Resource Setting.
    Int Q Community Health Educ. 2021 Apr 22:272684X211006608.
    PubMed    
    Abstract available

  212. GOMES FG, Almeida VH, Martins-Cardoso K, Martins-Dinis MMDC, et al
    Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications.
    Braz J Med Biol Res. 2021;54:e10754.
    PubMed    
    Abstract available

  213. MANNE R, Thakkar P, Zheng J
    Radiation-Induced Obturator Nerve Injury in Cervical Cancer.
    J Rehabil Med Clin Commun. 2021;4:1000043.
    PubMed    
    Abstract available

  214. WANG W, Xie X, Zhou Z, Zhang H, et al
    Expression Analysis of MIST1 and EMT Markers in Primary Tumor Samples Points to MIST1 as a Biomarker of Cervical Cancer.
    Int J Gen Med. 2021;14:1293-1300.
    PubMed    
    Abstract available

  215. QIU T, Lan Y, Wei Z, Zhang Y, et al
    In vivo Multi-scale Photoacoustic Imaging Guided Photothermal Therapy of Cervical Cancer based on Customized Laser System and Targeted Nanoparticles.
    Int J Nanomedicine. 2021;16:2879-2896.
    PubMed    
    Abstract available

  216. FERRE M, Varela Cagetti L, Zemmour C, Tyran M, et al
    Reducing dose to rectum by placement of a rectum-emptying tube in cervical cancer patients treated with brachytherapy.
    Brachytherapy. 2021 Apr 18. pii: S1538-4721(21)00057.
    PubMed    
    Abstract available

  217. MILES TT, Riley-Powell AR, Lee GO, Gotlieb EE, et al
    Knowledge, attitudes, and practices of cervical cancer prevention and pap smears in two low-income communities in Lima, Peru.
    BMC Womens Health. 2021;21:168.
    PubMed    
    Abstract available

  218. CHEN Y, Lin X, Zheng J, Chen J, et al
    APLN: A potential novel biomarker for cervical cancer.
    Sci Prog. 2021;104:368504211011341.
    PubMed    
    Abstract available

  219. LIU Y, Tu H, Zhang L, Xiong J, et al
    FOXP3induced LINC00885 promotes the proliferation and invasion of cervical cancer cells.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  220. CHEN S, Yang X, Yu C, Zhou W, et al
    The Potential of circRNA as a Novel Diagnostic Biomarker in Cervical Cancer.
    J Oncol. 2021;2021:5529486.
    PubMed    
    Abstract available

  221. TANG JH, Smith JS, McGue S, Gadama L, et al
    Prevention of cervical cancer through two HPV-based screen-and-treat implementation models in Malawi: protocol for a cluster randomized feasibility trial.
    Pilot Feasibility Stud. 2021;7:98.
    PubMed    
    Abstract available

  222. PAKEN J, Govender CD, Pillay M, Ayele BT, et al
    Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.
    BMC Womens Health. 2021;21:164.
    PubMed    
    Abstract available

  223. KJAER SK, Dehlendorff C, Belmonte F, Baandrup L, et al
    Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227603. doi: 10.1093.
    PubMed    
    Abstract available

  224. TANG MY, You ZX
    [Optimizing biopsy procedures during colposcopy and detection of high-grade cervical lesions].
    Zhonghua Fu Chan Ke Za Zhi. 2021;56:192-199.
    PubMed    
    Abstract available

  225. ASH J, Tsai A
    Metastatic Cervical Cancer to the Duodenum: A Learning Point.
    Cureus. 2021;13:e13874.
    PubMed    
    Abstract available

  226. CHRISTLEY S, Ostmeyer J, Quirk L, Zhang W, et al
    T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates.
    Front Immunol. 2021;12:624230.
    PubMed    
    Abstract available

  227. SUZUMURA EA, Gama LM, Jahn B, Campolina AG, et al
    Effects of 3D image-guided brachytherapy compared to 2D conventional brachytherapy on clinical outcomes in patients with cervical cancer: A systematic review and meta-analyses.
    Brachytherapy. 2021 Apr 15. pii: S1538-4721(21)00049.
    PubMed    
    Abstract available

  228. ISOHASHI F, Akino Y, Matsumoto Y, Suzuki O, et al
    Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer.
    J Radiat Res. 2021 Apr 19. pii: 6232580. doi: 10.1093.
    PubMed    
    Abstract available

  229. RODRIGUEZ NM
    Participatory innovation for human papillomavirus screening to accelerate the elimination of cervical cancer.
    Lancet Glob Health. 2021;9:e582-e583.
    PubMed    


  230. ZHENG S, Zhang X, Greuter MJW, de Bock GH, et al
    Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  231. WU X, Lei J, Zhou B, Sun Q, et al
    MiR-628-5p Inhibits Cervical Carcinoma Proliferation and Promotes Apoptosis by Targeting VEGF.
    Am J Med Sci. 2021;361:499-508.
    PubMed    
    Abstract available

  232. BAO HL, Jin C, Wang S, Song Y, et al
    Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: A nationwide population-based study.
    J Infect. 2021 Feb 18. pii: S0163-4453(21)00084.
    PubMed    
    Abstract available

  233. SCHIFFMAN M, Wentzensen N
    Cervical Screening Performance.
    Am J Clin Pathol. 2021;155:616-620.
    PubMed    


  234. DE MATTOS RC, Guimaraes IDS, Thiago LS, de Melo AC, et al
    Evaluation of HIF-1alpha and VEGF-A expression in radiation-induced cystitis: A case-control study.
    Int Braz J Urol. 2021;47:295-305.
    PubMed    
    Abstract available

  235. KHODADADI AB, Redden DT, Scarinci IC
    HPV Vaccination Hesitancy Among Latina Immigrant Mothers Despite Physician Recommendation.
    Ethn Dis. 2020;30:661-670.
    PubMed    
    Abstract available

  236. TOUNKARA FK, Teguete I, Guedou FA, Keita B, et al
    Prevalence and Factors Associated With HIV and Sexually Transmitted Infections Among Female Sex Workers in Bamako, Mali.
    Sex Transm Dis. 2020;47:679-685.
    PubMed    
    Abstract available

  237. CHEN J, Gu P, Wu H
    Uncovering PD-L1 and CD8(+) TILS Expression and Clinical Implication in Cervical Squamous Cell Carcinoma.
    Biomed Res Int. 2020;2020:8164365.
    PubMed    
    Abstract available

  238. CHEN C, Fang Z, Wang Q, Li W, et al
    Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
    Eur J Surg Oncol. 2021;47:346-352.
    PubMed    
    Abstract available

  239. LARISH A, Yin L, Glaser G, Moore E, et al
    Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2021;164:369-374.
    PubMed    
    Abstract available

  240. ZHANG XY, Dong XM, Wang FP
    MiR-377-3p inhibits cell metastasis and epithelial-mesenchymal transition in cervical carcinoma through targeting SGK3.
    Eur Rev Med Pharmacol Sci. 2020;24:4687-4696.
    PubMed    
    Abstract available

  241. KOVACHEV SM
    Immunotherapy in patients with local HPV infection and high-grade squamous intraepithelial lesion following uterine cervical conization.
    Immunopharmacol Immunotoxicol. 2020;42:314-318.
    PubMed    
    Abstract available

  242. MCHOME BL, Kjaer SK, Manongi R, Swai P, et al
    HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women.
    Sex Transm Infect. 2020 Apr 8. pii: sextrans-2019-054263.
    PubMed    
    Abstract available

  243. BAI H, Yin H
    Engeletin suppresses cervical carcinogenesis in vitro and in vivo by reducing NF-kappaB-dependent signaling.
    Biochem Biophys Res Commun. 2020;526:497-504.
    PubMed    
    Abstract available

  244. TENG P, Hao M
    A population-based study of age-related associations between vaginal pH and the development of cervical intraepithelial neoplasia.
    Cancer Med. 2020;9:1890-1902.
    PubMed    
    Abstract available

  245. SABEENA S, Kuriakose S, Damodaran B, Ravishankar N, et al
    Human papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysis.
    J Gynecol Oncol. 2020;31:e20.
    PubMed    
    Abstract available

  246. IIJIMA M, Okonogi N, Nakajima NI, Morokoshi Y, et al
    Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
    J Gynecol Oncol. 2020;31:e19.
    PubMed    
    Abstract available

  247. YANG J, Yang J, Cao D, Shen K, et al
    Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery.
    J Gynecol Oncol. 2020;31:e16.
    PubMed    
    Abstract available

  248. KIM SI, Kim SJ, Suh DH, Kim K, et al
    Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions.
    J Gynecol Oncol. 2020;31:e13.
    PubMed    
    Abstract available

  249. OKONOGI N, Wakatsuki M, Kato S, Murata H, et al
    Significance of concurrent use of weekly cisplatin in carbon-ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score-matched analysis.
    Cancer Med. 2020;9:1400-1408.
    PubMed    
    Abstract available

  250. CATALDI JR, Habesland M, Anderson-Mellies A, Dempsey AF, et al
    The potential population-based impact of an HPV vaccination intervention in Colorado.
    Cancer Med. 2020;9:1553-1561.
    PubMed    
    Abstract available

  251. ROUSSET-JABLONSKI C, Reynaud Q, Perceval M, Nove-Josserand R, et al
    Improvement in contraceptive coverage and gynecological care of adult women with cystic fibrosis following the implementation of an on-site gynecological consultation.
    Contraception. 2019 Nov 28. pii: S0010-7824(19)30448.
    PubMed    
    Abstract available

  252. CAMPBELL HE, Gray AM, Watson J, Jackson C, et al
    Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial.
    Health Expect. 2020;23:202-211.
    PubMed    
    Abstract available

  253. YOSHIOKA H, Minami K, Odashima H, Miyakawa K, et al
    Outer Cutoff Value for the Box-Counting Method for Fractal Analysis of the Nucleus Using Kirsch Edge Detection.
    Acta Cytol. 2021;65:186-193.
    PubMed    
    Abstract available

  254. JONES TE, Onisko A, Austin RM
    Personalized Medicine and Cervical Screening: Development of Individualized Quantitative Risk Assessments for Cervical Adenocarcinoma and Adenocarcinoma in situ.
    Acta Cytol. 2021;65:158-164.
    PubMed    
    Abstract available

  255. RYU A, Nagata S, Kubo C, Ueda Y, et al
    Conventional Direct Smear Yields Diagnostic Indicators of Gastric-Type Mucinous Carcinoma Compared with Cytomorphological Features Identified by Liquid-Based Cervical Cytology.
    Acta Cytol. 2021;65:150-157.
    PubMed    
    Abstract available

  256. GUSTAFSON LW, Petersen LK, Bor P, Andersen B, et al
    Cervical cancer prevention among older women - challenges in screening, diagnostic workup, and treatment.
    Acta Obstet Gynecol Scand. 2021 Apr 18. doi: 10.1111/aogs.14162.
    PubMed    
    Abstract available

  257. MO XT, Leung TH, Tang HW, Siu MK, et al
    CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
    Br J Cancer. 2020;123:833-843.
    PubMed    
    Abstract available

  258. ARROYO MUHR LS, Lagheden C, Lei J, Eklund C, et al
    Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR.
    Br J Cancer. 2020 Oct 6. pii: 10.1038/s41416-020-01111.
    PubMed    
    Abstract available

  259. BIZZARRI N, Pedone Anchora L, Zannoni GF, Carbone V, et al
    Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study.
    Br J Cancer. 2021 Apr 14. pii: 10.1038/s41416-021-01384.
    PubMed    
    Abstract available

  260. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    PubMed    
    Abstract available

  261. PRINTZ C
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.
    PubMed    


  262. FLOBERG JM, Zhang J, Muhammad N, DeWees TA, et al
    Standardized Uptake Value for 18F-Fluorodeoxyglucose is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer.
    Clin Cancer Res. 2021 Apr 5. pii: 1078-0432.CCR-20-4450.
    PubMed    
    Abstract available

  263. FERRALL L, Lin KY, Roden RBS, Hung CF, et al
    Cervical Cancer Immunotherapy: Facts and Hopes.
    Clin Cancer Res. 2021 Apr 22. pii: 1078-0432.CCR-20-2833.
    PubMed    
    Abstract available

  264. CAMPANER AB, Fernandes GL
    Detection of transformation zone cells in liquid-based cytology and its comparison with conventional smears.
    Diagn Cytopathol. 2020;48:752-758.
    PubMed    
    Abstract available

  265. KANAI R, Ohshima K, Ishii K, Sonohara M, et al
    Discriminant analysis and interpretation of nuclear chromatin distribution and coarseness using gray-level co-occurrence matrix features for lobular endocervical glandular hyperplasia.
    Diagn Cytopathol. 2020;48:724-735.
    PubMed    
    Abstract available

  266. MATHEVET P, Lecuru F, Uzan C, Boutitie F, et al
    Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2).
    Eur J Cancer. 2021;148:307-315.
    PubMed    
    Abstract available

  267. MATSUO K, Huang Y, Matsuzaki S, Ragab OM, et al
    Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
    Gynecol Oncol. 2021 Mar 23. pii: S0090-8258(21)00171.
    PubMed    
    Abstract available

  268. LANDY R, Mathews C, Robertson M, Wiggins CL, et al
    A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.
    Gynecol Oncol. 2020 Sep 22. pii: S0090-8258(20)33850.
    PubMed    
    Abstract available

  269. LI C, Li X, You J, Liang B, et al
    Impact of radiation source activity on short- and long-term outcomes of cervical carcinoma patients treated with high-dose-rate brachytherapy: A retrospective cohort study.
    Gynecol Oncol. 2020 Sep 12. pii: S0090-8258(20)33854.
    PubMed    
    Abstract available

  270. FANG C, Zhang P, Yu A, Yang Y, et al
    Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without.
    Gynecol Oncol. 2021 Apr 12. pii: S0090-8258(21)00275.
    PubMed    
    Abstract available

  271. SPINILLO A, Dominoni M, Boschi AC, Cesari S, et al
    The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Gynecol Oncol. 2020;159:630-635.
    PubMed    
    Abstract available

  272. COHEN PA, Leung Y, Anderson L, van der Griend R, et al
    Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and
    Gynecol Oncol. 2020;159:623-629.
    PubMed    
    Abstract available

  273. BOGANI G, DI Donato V, Sopracordevole F, Ciavattini A, et al
    Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
    Gynecol Oncol. 2020;159:636-641.
    PubMed    
    Abstract available

  274. BAO H, Bi H, Zhang X, Zhao Y, et al
    Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
    Gynecol Oncol. 2020;159:171-178.
    PubMed    
    Abstract available

  275. HUH WK, Brady WE, Fracasso PM, Dizon DS, et al
    Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
    Gynecol Oncol. 2020 Jul 5. pii: S0090-8258(20)32317.
    PubMed    
    Abstract available

  276. BONAZZOLI E, Bellone S, Zammataro L, Gnutti B, et al
    Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
    Gynecol Oncol. 2020 Jun 26. pii: S0090-8258(20)32299.
    PubMed    
    Abstract available

  277. CAO D, Shen K, Chen Y, Xu Y, et al
    Value of endocervical curettage in follow-up for patients with cervical intraepithelial neoplasia stage 2+ after loop electrosurgical excision.
    Gynecol Oncol. 2020;158:584-589.
    PubMed    
    Abstract available

  278. FRUMOVITZ M, Westin SN, Salvo G, Zarifa A, et al
    Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract.
    Gynecol Oncol. 2020;158:570-575.
    PubMed    
    Abstract available

  279. BORGFELDT C, Soderlund-Strand A, Darlin Flygh L, Forslund O, et al
    HPV73 in cervical cancer and distribution of HPV73 variants in cervical dysplasia.
    Int J Cancer. 2021 Apr 9. doi: 10.1002/ijc.33590.
    PubMed    
    Abstract available

  280. IVERSEN L, Fielding S, Lidegaard O, Hannaford PC, et al
    Contemporary hormonal contraception and cervical cancer in women of reproductive age.
    Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33585.
    PubMed    
    Abstract available

  281. PARRA SG, Lopez-Orellana LM, Molina Duque AR, Carns JL, et al
    Reply to: Comments on Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer.
    Int J Cancer. 2021 Apr 4. doi: 10.1002/ijc.33586.
    PubMed    


  282. PRETORIUS RG, Belinson JL
    COMMENTS ON: CERVICAL CANCER PREVENTION IN EL SALVADOR: A PROSPECTIVE EVALUATION OF SCREENING AND TRIAGE STRATEGIES INCORPORATING HIGH-RESOLUTION MICROENDOSCOPY TO DETECT CERVICAL PRECANCER.
    Int J Cancer. 2021 Apr 4. doi: 10.1002/ijc.33587.
    PubMed    


  283. CUZICK J, Adcock R, Carozzi F, Gillio-Tos A, et al
    Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
    Int J Cancer. 2020;147:1864-1873.
    PubMed    
    Abstract available

  284. EL-ZEIN M, Cheishvili D, Gotlieb W, Gilbert L, et al
    Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
    Int J Cancer. 2020;147:1264-1274.
    PubMed    
    Abstract available

  285. ZHAO XL, Xu XQ, Duan XZ, Rezhake R, et al
    Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: a population-based study in rural China.
    Int J Cancer. 2020 Jan 22. doi: 10.1002/ijc.32881.
    PubMed    
    Abstract available

  286. CHAN K, Liu SS, Wei N, Ngu SF, et al
    Primary HPV testing with cytology versus cytology alone in cervical screening - a prospective randomized controlled trial (RCT) with two rounds of screening in a Chinese population.
    Int J Cancer. 2020 Jan 10. doi: 10.1002/ijc.32861.
    PubMed    
    Abstract available

  287. FARNSWORTH A, Roberts JM, Garland SM, Crescini J, et al
    Detection of high-grade cervical disease among women referred directly to colposcopy following a positive HPV screening test varies with age and cytology findings.
    Int J Cancer. 2020 Jun 2. doi: 10.1002/ijc.33128.
    PubMed    
    Abstract available

  288. MALAGON T, Volesky KD, Bouten S, Laprise C, et al
    Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis.
    Int J Cancer. 2020;147:2695-2707.
    PubMed    
    Abstract available

  289. PINHEIRO M, Gage JC, Clifford GM, Demarco M, et al
    Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention.
    Int J Cancer. 2020;147:2677-2686.
    PubMed    
    Abstract available

  290. REZHAKE R, Chen F, Hu SY, Zhao XL, et al
    Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China.
    Int J Cancer. 2020;147:2053-2064.
    PubMed    
    Abstract available

  291. JENKINS D, Molijn A, Kazem S, Pirog EC, et al
    Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
    Int J Cancer. 2020 May 31. doi: 10.1002/ijc.33124.
    PubMed    
    Abstract available

  292. XUE Z, Novetsky AP, Einstein MH, Marcus JZ, et al
    A demonstration of automated visual evaluation of cervical images taken with a smartphone camera.
    Int J Cancer. 2020;147:2416-2423.
    PubMed    
    Abstract available

  293. KEMPER KE, McGrath CJ, Eckert LO, Kinuthia J, et al
    Correlates of cervical cancer screening among women living with HIV in Kenya: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 Mar 30. doi: 10.1002/ijgo.13690.
    PubMed    
    Abstract available

  294. MARINGA VD, Chikandiwa A, Gilham C, Mbodi L, et al
    Performance of the Swede score to predict cervical intraepithelial neoplasia in women with HIV-1 in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2021;152:188-195.
    PubMed    
    Abstract available

  295. MAENE C, Salihi RR, Van Nieuwenhuysen E, Han SN, et al
    Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer.
    Int J Gynecol Cancer. 2021 Apr 15. pii: ijgc-2021-002432.
    PubMed    
    Abstract available

  296. CORINTI M, Alvarenga-Bezerra V, Ribeiro R, Liao AW, et al
    Extraperitoneal laparoscopic pelvic lymphadenectomy for cervical cancer staging in twin pregnancy.
    Int J Gynecol Cancer. 2021 Apr 13. pii: ijgc-2021-002410.
    PubMed    


  297. OLTHOF EP, Mom CH, van der Velden J
    More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri.
    Int J Gynecol Cancer. 2020;30:1850.
    PubMed    


  298. CHAUDARY N, Hill RP, Stulik L, Milosevic M, et al
    The oral CXCR4 inhibitor X4-136 improves tumor control and reduces toxicity in cervical cancer treated with radiotherapy and concurrent chemotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Mar 23. pii: S0360-3016(21)00291.
    PubMed    
    Abstract available

  299. HARARI PM, Lambert PF
    Life Beyond COVID: Pay Attention to Viruses.
    Int J Radiat Oncol Biol Phys. 2020;108:348-350.
    PubMed    


  300. DYER BA, Mayadev JS
    Restage and Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:849-850.
    PubMed    


  301. SON CH, Hasan Y
    A Parametrial Problem.
    Int J Radiat Oncol Biol Phys. 2020;108:849.
    PubMed    


  302. SINGER L, Lee LJ
    50 Gray is Not Enough.
    Int J Radiat Oncol Biol Phys. 2020;108:848-849.
    PubMed    


  303. CHINO J, Damast S, Kidd E, Harkenrider M, et al
    Radiation for Cancers of the Uterine Corpus and Cervix: Incremental Steps, and Glimmers of the Future.
    Int J Radiat Oncol Biol Phys. 2020;108:839-845.
    PubMed    


  304. MAO X, Pineau J, Keyes R, Enger SA, et al
    RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
    Int J Radiat Oncol Biol Phys. 2020;108:802-812.
    PubMed    
    Abstract available

  305. RAUT A, Chopra S, Mittal P, Patil G, et al
    FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:1248-1256.
    PubMed    
    Abstract available

  306. YUSUFALY T, Miller A, Medina-Palomo A, Williamson CW, et al
    A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:1240-1247.
    PubMed    
    Abstract available

  307. OUYANG F, Liu J, Xia M, Lin C, et al
    [Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in earlystage cervical cancer.
    Oncol Rep. 2021;45.
    PubMed    
    Abstract available

  308. MOHAMMADI R, Shokatian I, Salehi M, Arabi H, et al
    Deep learning-based Auto-segmentation of Organs at Risk in High-Dose Rate Brachytherapy of Cervical Cancer.
    Radiother Oncol. 2021 Apr 5. pii: S0167-8140(21)06170.
    PubMed    
    Abstract available

  309. DUKE SL, Tan LT, Jensen NBK, Rumpold T, et al
    Implementing an online radiotherapy quality assurance programme with supporting continuous medical education - report from the EMBRACE-II evaluation of cervix cancer IMRT contouring.
    Radiother Oncol. 2020;147:22-29.
    PubMed    
    Abstract available

  310. SPAMPINATO S, Tanderup K, Marinovskij E, Axelsen S, et al
    MRI-based contouring of functional sub-structures of the lower urinary tract in gynaecological radiotherapy.
    Radiother Oncol. 2020;145:117-124.
    PubMed    
    Abstract available

  311. SCHMID MP, Fokdal L, Westerveld H, Chargari C, et al
    Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.
    Radiother Oncol. 2020;145:36-44.
    PubMed    
    Abstract available

  312. SWAMIDAS J, Kirisits C, De Brabandere M, Hellebust TP, et al
    Image registration, contour propagation and dose accumulation of external beam and brachytherapy in gynecological radiotherapy.
    Radiother Oncol. 2020;143:1-11.
    PubMed    
    Abstract available

  313. TRAVERSO A, Kazmierski M, Welch ML, Weiss J, et al
    Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patients.
    Radiother Oncol. 2020;143:88-94.
    PubMed    
    Abstract available

  314. MA D, Pan Z, Chang Q, Zhang JJ, et al
    KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.
    BMC Cancer. 2021;21:377.
    PubMed    
    Abstract available

  315. TISLER A, Ojavee SE, Veerus P, Soodla P, et al
    Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.
    BMC Cancer. 2021;21:350.
    PubMed    
    Abstract available

  316. LIU H, Ye X, Li D, Yao Q, et al
    Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study.
    BMC Cancer. 2021;21:421.
    PubMed    
    Abstract available

  317. CHEN M, Wang H, Liang Y, Hu M, et al
    Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.
    BMC Cancer. 2020;20:926.
    PubMed    
    Abstract available

  318. LEE F, Bula A, Chapola J, Mapanje C, et al
    Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
    BMC Cancer. 2021;21:428.
    PubMed    
    Abstract available

  319. LI Y, Chen Z, Wang X, Li X, et al
    Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy.
    BMC Cancer. 2021;21:442.
    PubMed    
    Abstract available

  320. BOGALE AL, Teklehaymanot T, Haidar Ali J, Kassie GM, et al
    Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis.
    PLoS One. 2021;16:e0249960.
    PubMed    
    Abstract available

  321. NGCAMPHALALA C, Ostensson E, Ginindza TG
    The economic burden of cervical cancer in Eswatini: Societal perspective.
    PLoS One. 2021;16:e0250113.
    PubMed    
    Abstract available

  322. JUBAIR L, Lam AK, Fallaha S, McMillan NAJ, et al
    CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice.
    PLoS One. 2021;16:e0223288.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;